AWS And Bluesight Put Prism Assistant Across 20 Health Systems
AI News reported that AWS and Bluesight have moved the ControlCheck Prism Assistant to general availability across 20 health systems, while a separate 340B GPO compliance agent remains scheduled for later in 2026. AWS cited faster report generation and synthetic-test results, while named hospital customers, pricing and production results for the planned GPO agent remain outside the public account.
The ControlCheck Prism Assistant is now generally available across 20 health systems, according to AI News, which cited AWS vendor statements about Bluesight’s hospital compliance AI work.
A separate multi-product agent for 340B Group Purchasing Organisation compliance remains scheduled for later in 2026.
AWS framed the project as hospital pharmacy and compliance workflow software rather than a general chatbot rollout.
Its account estimates that one covered entity in the 340B programme can spend more than 4,000 staff hours a year checking whether GPO drug purchases qualify for an exception, using shortage notices, pharmacy records, inventory data, machine-learning forecasts and back-order records.
Prism Assistant Runs Across 20 Health Systems
Bluesight built Prism Assistant for ControlCheck, its controlled-substance monitoring product.
Hospital diversion teams use ControlCheck to identify unusual medication transaction patterns, while compliance staff previously assembled case documentation, reviewed dashboards and matched findings manually.
The assistant gives users a conversational interface for ControlCheck data, chart creation and investigative material.
AWS dates the first build to a September 2025 Experience-Based Acceleration engagement with eight Bluesight engineers, seven AWS specialists and a three-day timetable.
The production deployment uses Strands Agents with Amazon Bedrock and is hosted through Amazon Bedrock AgentCore Runtime.
AWS documentation lists AgentCore Gateway as exposing more than 10 ControlCheck APIs as MCP tools, allowing the agent to find and call approved product functions during a user request.
AWS Lists Bedrock AgentCore And MCP Tooling
The architecture keeps the language model away from direct database access.
Bluesight wrapped existing ControlCheck API endpoints in AWS Lambda functions that return structured data for agent processing, while business logic stays inside the application layer.
AWS measurements put query latency at 10 seconds, down from five minutes.
The deployment also includes chart generation, observability controls, cost attribution, encryption, authentication and infrastructure-as-code.
Samir Neyazi, director of product management, described the tool as getting diversion programme leaders to answers faster and removing manual work from investigations.
The service reached general availability in under nine months, while the 20 health systems represent the active deployment evidence disclosed publicly.
340B GPO Agent Remains Scheduled For 2026
The planned GPO agent is narrower and more regulated.
Federal 340B rules prohibit certain hospitals from using GPO contracts for outpatient drugs when non-GPO channels can supply the drug, and compliance teams must document exceptions when supply conditions block that route.
Bluesight’s planned system brings together CostCheck purchase records, ShortageCheck drug-availability evidence and 340BCheck eligibility data.
The architecture uses Anthropic Claude Sonnet 4.6 as the main model and Claude Haiku 4.5 for lower-latency operations through Amazon Bedrock.
A coordinating GPO agent assigns work to specialist data agents for purchase records, supply evidence and 340B eligibility.
AWS records show that a March 2026 acceleration engagement connected the system by the end of its first day and completed planned features by the end of day two.
Synthetic Tests Stop Short Of Hospital Production Evidence
Synthetic test results list a 100 percent invoice discovery rate and 93 percent evidence justification accuracy, above an 85 percent target.
Those figures do not represent production performance across hospital customers.
The test record described prepared scenarios, not local data gaps, delayed shortage updates, unusual drug identifiers or disputed purchasing cases.
Bluesight assigns the language model a constrained role: it gathers records, calls product tools and drafts the explanation, while a deterministic scoring service calculates the compliance determination.
Technical documentation describes a deterministic scoring layer using 13 evidence inputs, priority matching and configurable time windows.
Hospital pharmacy, legal and compliance teams remain responsible for policy settings such as shortage thresholds, inventory periods and purchase-date windows.
AWS And Bluesight List HIPAA And Audit Controls
The AWS account lists HIPAA eligibility for Amazon Bedrock and identifies Bluesight as operating under a Business Associate Agreement with the cloud provider.
Amazon Bedrock does not train foundation models on customer data processed through the service.
The deployment uses Amazon Cognito for OAuth2 client-credential authentication and JSON Web Token validation.
AgentCore Runtime isolates concurrent customer sessions, Key Management Service encrypts data at rest and in transit, and Secrets Manager handles downstream credentials.
CloudWatch records agent decisions, tool invocations, data-access events, alarms and performance metrics.
Bluesight’s internal measurements across 20 health systems reported up to 97 percent faster report generation and analysis in ControlCheck workflows, including recurring analyses moving from about six hours of manual assembly to 15 minutes.
The remaining public-record gaps are customer names, pricing, hospital-level production performance for the GPO agent and a more precise launch date.
